Anxiety Shows Stronger Connection to Inflammatory and Hormonal Changes
A team of researchers from several European universities published new findings in Psychoneuroendocrinology this week. The work examined how bodily stress signals, often linked to depressive disorders, relate to anxiety and depression in a sample of over 1,200 adults aged 18‑65. Results indicate that anxiety, not depression, better predicts chronic‑stress biomarkers.
Wellness insights
Lived Experience Transforms Mental Health Research Approaches
Finding Freedom in Familiar Spaces
Fingertip Sensor Detects Mental Distress Patterns
The Essential Library for Lasting Personal TransformationThe investigators measured participants’ blood levels of inflammatory proteins such as C‑reactive protein and interleukin‑6, alongside daily cortisol patterns obtained from saliva. They also administered standardized questionnaires to assess anxiety and depressive symptoms. Statistical analysis revealed that higher anxiety scores consistently aligned with elevated inflammation and disrupted cortisol rhythms, whereas depressive scores showed weaker or no such associations. Lead author Dr. Elena Marquez explained that the data „challenge the long‑standing assumption that depression is the primary driver of these physiological changes.”
The study’s biomarker analysis highlighted a clear pattern: participants reporting frequent worry, tension, or nervousness displayed significantly higher levels of systemic inflammation. In contrast, those whose primary complaints were low mood or anhedonia did not exhibit the same biological elevation. Researchers suggest that the sympathetic nervous system activation typical of anxiety may trigger immune responses, leading to the observed inflammation. Moreover, cortisol—a hormone that regulates stress—was found to follow a flatter diurnal slope in anxious individuals, indicating a less resilient stress response.
Does This Rethink How We View Depression‑Related Stress Markers?
These findings align with earlier animal research linking chronic anxiety to immune dysregulation. The authors caution, however, that correlation does not prove causation. They advocate for longitudinal studies to determine whether anxiety directly induces these physiological shifts or whether a third factor underlies both.
The results raise questions about the conventional view that depression is the main source of stress‑related bodily changes. If anxiety drives the majority of biomarker alterations, clinicians may need to adjust diagnostic and treatment strategies. Dr. Marquez noted that „targeting anxiety‑specific pathways could improve outcomes for patients who present with both mood and physical symptoms.” She also emphasized that depression remains a serious condition, but its biological footprint may differ from that of anxiety.
Future research may explore interventions that reduce anxiety‑induced inflammation, such as mindfulness‑based stress reduction or specific pharmacotherapies. Understanding the distinct biological signatures of anxiety and depression could lead to more personalized mental‑health care and better prevention of chronic diseases linked to stress.
Frequently Asked Questions
What types of stress markers were examined? The study focused on inflammatory proteins (CRP, IL‑6) and cortisol patterns, both widely recognized as indicators of chronic physiological stress.
Can anxiety cause physical illness? Elevated inflammation and altered cortisol are risk factors for cardiovascular disease, diabetes, and immune disorders, suggesting that persistent anxiety may increase long‑term health risks.
Should treatment focus shift from depression to anxiety? While depression still requires attention, the findings suggest that addressing anxiety symptoms may be crucial for reducing stress‑related bodily effects in many patients.
